Project Overview +

This consultant project provides expert advice to Roche Pharmaceuticals on the development of the Xenicare II program, a personalized support program available to consumers who use Xenical, a weight control drug.

Aims +

Aim 1. Review a proposal by MicroMass Communications to Roche Pharmaceuticals to develop the tailored XeniCare II education and compliance program.

Aim 2. Make recommendations in the areas of survey design, message composition, strength and use of tailoring including use of theory, number and timing of printed materials, and creative design.

Participants +

This is not a study - there are no participants.

Intervention +

The HMRL's consultation includes recommendations in the following areas:

  • Survey design
  • Message composition
  • Strength and use of tailoring including use of theory
  • Number and timing of printed materials
  • Creative design

Findings +

XeniCare II

10/01/1999 - 12/31/1999


Roche Pharmaceuticals

Principal Investigator:

Victor J. Strecher, PhD, MPH